Cromoglicic acid: Difference between revisions
m Citations: [Pu161]+: format, pmc. Tweaked: issue. You can use this bot yourself! Report bugs here. |
DieselDoctor (talk | contribs) |
||
| Line 51: | Line 51: | ||
* as [[eye drop]]s (Opticrom and Optrex Allergy (UK), Crolom) for [[allergic conjunctivitis]] |
* as [[eye drop]]s (Opticrom and Optrex Allergy (UK), Crolom) for [[allergic conjunctivitis]] |
||
* in an oral form (Gastrocrom) to treat [[mastocytosis]],<ref name="pmid2110198">{{cite journal |author=Horan RF, Sheffer AL, Austen KF |title=Cromolyn sodium in the management of systemic mastocytosis |journal=J. Allergy Clin. Immunol. |volume=85 |issue=5 |pages=852–5 |year=1990 |month=May |pmid=2110198 |doi= 10.1016/0091-6749(90)90067-E |
* in an oral form (Gastrocrom) to treat [[mastocytosis]],<ref name="pmid2110198">{{cite journal |author=Horan RF, Sheffer AL, Austen KF |title=Cromolyn sodium in the management of systemic mastocytosis |journal=J. Allergy Clin. Immunol. |volume=85 |issue=5 |pages=852–5 |year=1990 |month=May |pmid=2110198 |doi= 10.1016/0091-6749(90)90067-E}}}}</ref> [[dermatographic urticaria]] and [[ulcerative colitis]]. Another oral product, Intercron (sodium cromoglicate in distilled water, from [[Zambon]] France), is used for food allergies. |
||
==Mechanism of action== |
==Mechanism of action== |
||
Revision as of 01:15, 27 July 2010
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | topical: oral, nasal spray, inhaled, eye drops |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 1% |
| Elimination half-life | 1.3 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.036.602 |
| Chemical and physical data | |
| Formula | C23H16O11 |
| Molar mass | 468.367 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Cromoglicic acid (INN) (also referred to as cromolyn (USAN), cromoglycate (former BAN), or cromoglicate) is traditionally described as a mast cell stabilizer, and is commonly marketed as the sodium salt sodium cromoglicate or cromolyn sodium. This drug prevents the release of inflammatory chemicals such as histamine from mast cells.
Because of their convenience (and perceived safety), leukotriene receptor antagonists have largely replaced it as the non-corticosteroid treatment of choice. Cromoglicic acid requires administration four times daily, and does not provide additive benefit in combination with inhaled corticosteroids.[1]
History
Cromolyn sodium was discovered by Dr. Roger Altounyan who was himself a lifelong asthma sufferer. It is considered a breakthrough drug in management of asthma as the patients can be freed from steroids in many cases, however, it is mainly effective as a prophylaxis for allergic and exercise induced asthma, not as a treatment for acute attacks. Dr. Altounyan was investigating certain plants and herbs which have bronchodilating properties. One such plant was Khella (Ammi visnaga) which had been used as a muscle relaxant since ancient times in Egypt. Dr. Altounyan deliberately inhaled derivatives of the active ingredient khellin to determine if they could block his asthma attacks. After several years of trial he isolated an effective and safe asthma-preventing compound called cromolyn sodium.
Preparations
Cromoglicic acid is available in multiple forms:
- as a nasal spray (Rynacrom(UK), Nasalcrom, Prevalin (Netherlands)) to treat allergic rhinitis.
- in a nebulizer solution for aerosol administration to treat asthma.
- as an inhaler (Intal) for preventive management of asthma[2]. The maker of Intal, King Pharmaceuticals, has discontinued manufacturing the inhaled form, cromolyn sodium inhalation aerosol, due to issues involving CFC-free propellant. As stocks are depleted, this inhaler preparation will no longer be available to patients.[3]
- as eye drops (Opticrom and Optrex Allergy (UK), Crolom) for allergic conjunctivitis
- in an oral form (Gastrocrom) to treat mastocytosis,[4] dermatographic urticaria and ulcerative colitis. Another oral product, Intercron (sodium cromoglicate in distilled water, from Zambon France), is used for food allergies.
Mechanism of action
"Cromolyn works because it prevents the release of mediators that would normally attract inflammatory cells and because it stabilizes the inflammatory cells."[5] The underlying mechanism of action is not fully understood; for while cromoglicate stabilizes mast cells, this mechanism is probably not why it works in asthma.[6] Pharmaceutical companies have produced 20 related compounds that are equally or more potent at stabilising mast cells and none of them have shown any anti-asthmatic effect.[6] It is more likely that these work by inhibiting the response of sensory C fibres to the irritant capsaicin, inhibiting local axon reflexes involved in asthma, and may inhibit the release of preformed T cell cytokines and mediators involved in asthma. (see review by Garland, 1991)
It is known to somewhat inhibit chloride channels (37% +/- 7%) [7] and thus may inhibit the:
- exaggerated neuronal reflexes triggered by stimulation of irritant receptors on sensory nerve endings (e.g. exercise-induced asthma)
- release of preformed cytokines from several type of inflammatory cells (T cells, eosinophils) in allergen-induced asthma
Note: Another chemical (NPPB: 5-nitro-2(3-phenyl) propylamino-benzoic acid) was shown, in the same study, to be a more effective chloride channel blocker.
Finally it may act by inhibiting calcium influx.
Cromoglicate is classified as a chromone.
References
- ^ Fanta CH (2009). "Asthma". New England Journal of Medicine. 360 (10): 1002–14. doi:10.1056/NEJMra0804579. PMID 19264689.
{{cite journal}}: Unknown parameter|month=ignored (help) Review. - ^ Schwartz HJ, Blumenthal M, Brady R; et al. (1996). "A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?". Chest. 109 (4): 945–52. doi:10.1378/chest.109.4.945. PMID 8635375.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ http://www.empr.com/Intal-Inhaler-discontinued/article/141142/
- ^ Horan RF, Sheffer AL, Austen KF (1990). "Cromolyn sodium in the management of systemic mastocytosis". J. Allergy Clin. Immunol. 85 (5): 852–5. doi:10.1016/0091-6749(90)90067-E. PMID 2110198.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)}} - ^ Werner's Pathophysiology page 224
- ^ a b H. P. Rang et al., Pharmacology, Fifth Edition. (2003) ISBN 0 443 07145 4
- ^ Heinke, S (1995). "Inhibition of volume-activated chloride currents in endothelial cells by chromones". Br J Pharmacol. 115(8) (8): 1393–8. PMC 1908889. PMID 8564197.
{{cite journal}}: Cite has empty unknown parameter:|quotes=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help); Unknown parameter|month=ignored (help)